The role of hyaluronic acid and its benefit in patients affected by mild-to-moderate glenohumeral osteoarthritis

The role of hyaluronic acid in patients affected by glenohumeral osteoarthritis.

Article specifications

This clinical trial was published in 2015 in Journal of J Biol Regul Homeost Agents. (IF: 2015: 1.36) by Italian specialists. The aim of this manuscript is to examine the role of hyaluronic acid and its benefit in patients affected by mild-to-moderate glenohumeral osteoarthritis.

 

Results

The present study demonstrates the greater and long-lasting efficacy of a five-injection treatment with hyaluronic acid (Hyalgan 20mg/2ml) combined with a physical therapy program in comparison with physical therapy only in patients affected by glenohumeral osteoarthritis degree I, II or III.